Results for tag: "Ipilimumab"

Ipilimumab is a monoclonal antibody drug used in the treatment of lung cancer. It works by targeting a protein called cytotoxic T-lymphocyte antigen 4 (CTLA-4), which is found on the surface of certain immune cells. By blocking CTLA-4, ipilimumab helps the body's immune system to recognize and attack cancer cells. It is approved for use in combination with other drugs for the treatment of metastatic non-small cell lung cancer (NSCLC). Ipilimumab is a relatively new drug, having been approved by the US Food and Drug Administration (FDA) in 2015. It is currently used in combination with other drugs, such as nivolumab, to treat NSCLC. It is also being studied in combination with other drugs for the treatment of other types of cancer, such as melanoma and colorectal cancer. Ipilimumab is marketed by several companies, including Bristol-Myers Squibb, Merck, and AstraZeneca. It is also available in generic form from several generic drug manufacturers. Show Less Read more